Evidence map›Paper›PMID 20166886›Full record

ArticleFree radical research2010

S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: involvement of adenosine metabolites.

Herve Y Sroussi, Yu Lu, Qin L Zhang, Dana Villines, Phillip T Marucha

Abstract read
In one paragraph

Article in Free radical research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Assessment of changes in genetic transcriptome in nasal epithelial cells exposed to ozone-aged black carbon and pollen allergen by high-throughput transcriptomics.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  12. Review
  13. Review
  14. Protective role of DJ-1 in endotoxin-induced acute kidney injury.American journal of physiology. Renal physiology · 2020
    Article
  15. A NovelJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  16. Review
  17. Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Herve Y SroussiDepartment of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois at Chicago, Chicago, IL 60612-7213, USA. sroussih@uic.edu
Yu Lu
Qin L Zhang
Dana Villines
Phillip T Marucha
Illinois College · USWound Healing Society · US

Funding

CALPROTECTIN AS A MOLECULAR SENSOR AND REGULATOR OF OXIDATION IN WOUND HEALINGK22DE017161 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SROUSSI, HERVE Y · 2006 to 2009
$637k
NIDCR NIH HHS K22 DE017161NIDCR NIH HHS K22DE017161
6 · The paper itself

Abstract

Neutrophils are short-lived granulocytic cells of the innate immune system specialized in the production of reactive oxygen species. S100A8 and S100A9 and their heterocomplex calprotectin play a role in neutrophil recruitment and represent 40% of neutrophil cytosolic protein weight. The present study was designed to test the effect of S100A8 and S100A9 on the rate of neutrophil oxidative metabolism. It is hypothesized that the two S100 proteins inhibit neutrophil associated oxidation. Granulocytes freshly isolated from healthy volunteers were tested for their ability to oxidize dichlorofluorescindiacetate (DCFH-DA) in-vitro. The data showed that S100A8 and S100A9 inhibited spontaneous and stimulated oxidation of the DCFH-DA probe by neutrophils. The inhibition of neutrophil oxidative metabolism by S100A8 and S100A9 was markedly reduced by the enzymatic activity of adenosine deaminase. Inhibitors of the P1 adenosine receptors also reduced the anti-oxidative effect of S100A8/A9 providing further support for the involvement of adenosine metabolites in S100A8/ A9 anti-oxidative effect.

Indexed as

Neutrophil ActivationAdenosineAdenosine DeaminaseCalgranulin ACalgranulin BEnzyme ActivationEnzyme ActivatorsEnzyme InhibitorsFluoresceinsFluorescent DyesHumansNeutrophilsOxidation-ReductionProtein Kinase CPurinergic P1 Receptor AntagonistsReactive Oxygen SpeciesAdenosineAdenosine DeaminaseCalgranulin ACalgranulin BdiacetyldichlorofluoresceinEnzyme ActivatorsEnzyme InhibitorsFluoresceinsFluorescent DyesProtein Kinase CPurinergic P1 Receptor AntagonistsReactive Oxygen SpeciesReceptors, Purinergic P1Recombinant Proteins

Identifiers

PMID20166886
PMCPMC2836424
OpenAlexW2172243279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.